Safety and Efficacy Study of Bimatoprost in the Treatment of Men With Androgenic Alopecia
Status:
Completed
Trial end date:
2012-09-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the safety and efficacy of 3 doses of bimatoprost solution compared
with vehicle and over-the-counter (OTC) minoxidil 5% solution in men with androgenic
alopecia. All treatments will be provided in a double-blinded fashion except for minoxidil 5%
solution which will be provided open-label.